KRT5 and breast cancer: Most cases of TNBC (80%) also share characteristics of basal-like breast cancers (BLBCs) because the expression of basal markers, such as CK5/6 or epidermal growth factor receptor (EGFR), which are identified by gene expression profiling4, 8, 10, 11, 12, 13, 14.